Loading market dashboard
Acorda Therapeutics, Inc.
ACORHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Acorda Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2025 | $163.09M | $163.09M - $163.09M | -$18.79M | -$34.20 | 1 |
| Dec 2024 | $138.92M | $138.92M - $138.92M | -$16.00M | -$52.40 | 1 |
| Dec 2023 | $110.91M | $110.91M - $110.91M | $99.20M | -$94.60 | 1 |
| Dec 2022 | $120.52M | $120.52M - $120.52M | $106.09M | -$19.20 | 1 |
| Dec 2021 | $120.38M | $120.38M - $120.38M | $113.47M | -$152.80 | 1 |
| Dec 2020 | $148.81M | $148.81M - $148.81M | -$17.14M | -$60.80 | 1 |
| Dec 2019 | $188.00M | $188.00M - $188.00M | -$218.82M | -$526.56 | 1 |
| Dec 2018 | $450.12M | $450.12M - $450.12M | $230.34M | $101.28 | 14 |
| Dec 2017 | $571.58M | $571.58M - $571.58M | -$280.19M | $191.10 | 14 |
| Dec 2016 | $518.18M | $518.18M - $518.18M | -$3.91M | $28.414 | 13 |
| Dec 2015 | $487.27M | $487.27M - $487.27M | $41.54M | $19.543 | 14 |
| Dec 2014 | $588.71M | $470.97M - $706.45M | $101.18M | $0.56 | 16 |